Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs AJANTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER AJANTA PHARMA PFIZER/
AJANTA PHARMA
 
P/E (TTM) x 38.7 42.3 91.5% View Chart
P/BV x 6.6 10.4 64.0% View Chart
Dividend Yield % 0.7 1.7 38.9%  

Financials

 PFIZER   AJANTA PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-24
AJANTA PHARMA
Mar-24
PFIZER/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs4,9402,355 209.8%   
Low Rs3,4801,208 288.1%   
Sales per share (Unadj.) Rs479.4334.2 143.4%  
Earnings per share (Unadj.) Rs120.564.8 185.9%  
Cash flow per share (Unadj.) Rs134.175.6 177.5%  
Dividends per share (Unadj.) Rs35.0051.00 68.6%  
Avg Dividend yield %0.82.9 29.0%  
Book value per share (Unadj.) Rs785.9282.9 277.8%  
Shares outstanding (eoy) m45.75125.92 36.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x8.85.3 164.8%   
Avg P/E ratio x34.927.5 127.1%  
P/CF ratio (eoy) x31.423.6 133.2%  
Price / Book Value ratio x5.46.3 85.1%  
Dividend payout %29.078.7 36.9%   
Avg Mkt Cap Rs m192,598224,309 85.9%   
No. of employees `000NANA-   
Total wages/salary Rs m3,4789,003 38.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m21,93242,087 52.1%  
Other income Rs m1,805846 213.4%   
Total revenues Rs m23,73742,933 55.3%   
Gross profit Rs m6,43311,719 54.9%  
Depreciation Rs m6231,354 46.0%   
Interest Rs m15472 214.0%   
Profit before tax Rs m7,46111,139 67.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,9472,978 65.4%   
Profit after tax Rs m5,5138,162 67.6%  
Gross profit margin %29.327.8 105.3%  
Effective tax rate %26.126.7 97.6%   
Net profit margin %25.119.4 129.6%  
BALANCE SHEET DATA
Current assets Rs m27,37827,221 100.6%   
Current liabilities Rs m5,4668,953 61.1%   
Net working cap to sales %99.943.4 230.2%  
Current ratio x5.03.0 164.7%  
Inventory Days Days11532 361.5%  
Debtors Days Days311 28.9%  
Net fixed assets Rs m14,05317,730 79.3%   
Share capital Rs m458253 181.0%   
"Free" reserves Rs m35,49835,364 100.4%   
Net worth Rs m35,95535,617 100.9%   
Long term debt Rs m00-   
Total assets Rs m41,74845,039 92.7%  
Interest coverage x49.4155.5 31.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.9 56.2%   
Return on assets %13.618.3 74.3%  
Return on equity %15.322.9 66.9%  
Return on capital %21.231.5 67.3%  
Exports to sales %3.956.7 6.8%   
Imports to sales %23.79.5 250.3%   
Exports (fob) Rs m84823,865 3.6%   
Imports (cif) Rs m5,2023,988 130.4%   
Fx inflow Rs m84823,865 3.6%   
Fx outflow Rs m5,2023,988 130.4%   
Net fx Rs m-4,35419,876 -21.9%   
CASH FLOW
From Operations Rs m2,5687,851 32.7%  
From Investments Rs m537654 82.1%  
From Financial Activity Rs m-2,351-10,511 22.4%  
Net Cashflow Rs m754-2,006 -37.6%  

Share Holding

Indian Promoters % 0.0 66.3 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 19.6 26.2 74.6%  
FIIs % 3.5 9.1 38.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 33.7 106.9%  
Shareholders   98,824 64,315 153.7%  
Pledged promoter(s) holding % 0.0 11.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    MANKIND PHARMA    


More on Pfizer vs AJANTA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Pfizer vs AJANTA PHARMA Share Price Performance

Period Pfizer AJANTA PHARMA S&P BSE HEALTHCARE
1-Day 1.81% 0.33% 1.23%
1-Month -5.07% -0.59% -0.24%
1-Year 27.47% 54.48% 43.62%
3-Year CAGR 1.91% 28.46% 20.35%
5-Year CAGR 5.29% 34.71% 26.24%

* Compound Annual Growth Rate

Here are more details on the Pfizer share price and the AJANTA PHARMA share price.

Moving on to shareholding structures...

The promoters of Pfizer hold a 63.9% stake in the company. In case of AJANTA PHARMA the stake stands at 66.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Pfizer and the shareholding pattern of AJANTA PHARMA.

Finally, a word on dividends...

In the most recent financial year, Pfizer paid a dividend of Rs 35.0 per share. This amounted to a Dividend Payout ratio of 29.0%.

AJANTA PHARMA paid Rs 51.0, and its dividend payout ratio stood at 78.7%.

You may visit here to review the dividend history of Pfizer, and the dividend history of AJANTA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 1,961 points | Nifty Above 23,900 | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.